Research & Development

香港日本三级在线播放伊人综合在线?偷拍诱人的老师电影在线华为被美制裁后欧洲市场遭抢夺 三星成最大赢家


  突然間,公孫敖怒眼環睜,不等翠衣婦人說話,一只碩大的拳頭就剛猛無儔的砸在婦人的臉上……   趁著那些人鼓噪的時刻,雲瑯立刻就收集了七八個蒲團,堆在一起倒頭就睡,然後他就看見了衛青那張似笑非笑的臉。香港日本三级在线播放   雲瑯的目光依舊落在書本上,沒有任何反應,褚狼就關好門,走了出去。伊人综合在线?偷拍 第一七六章 儒家獨大   太尉府爭吵的消息很快就鑽進了劉徹的耳朵。诱人的老师电影在线   曹襄笑道︰“一千六百個蒙學,曹氏不久將會全面啟動。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo